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causes of death have shifted from infectious to lifestyle-
related diseases. Deterioration in diet and decline in
physical activity have led to hypertension, obesity,
diabetes, and CV disease.1 The World Health Organiza-
tion (WHO) has recently issued reports to raise awareness
and called for efforts to halt the rapid progression of non-
communicable diseases, which is disproportionately high
in low- and middle-income countries (LMICs).2 Because
lifestyle and cardiovascular risk factors tend to cluster
within the same individual,3,4 cardiovascular prevention
strategies should focus on comprehensive interventions
addressing multiple risk factors rather than isolated ones.
The call to address the increasing prevalence of non-
communicable diseases worldwide motivated the devel-
opment of the Grenada Heart Project. With support from
the Grenadian Ambassador to the UN, our team initiated a
nation-wide survey of CV risk. Among 2827 randomly
selected participants, prevalence rates of obesity, hyper-
tension and diabetes significantly exceeded those seen in
the United States.5,6 Nearly 60% of the participants were
overweight or obese, one quarter were physically
inactive, and 13% had diabetes. The self-reported rate of
heart disease was 6%, paradoxically lower than expected
given the prevalence of risk factors.5
The next step was to design a low-cost scalable
intervention and test it. Our research group conducted
a community-based health promotion trial in Spain with
543 participants called the “Fifty-Fifty” Program.7,8 This
study demonstrated that an “Alcoholics Anonymous”
style peer motivation groups may significantly improve
healthy behaviors and therefore decrease CV risk.8
The GHP-CHANGE was developed to extend the
findings in Spain to a LMIC, and study the effects of
peer education groups on their CV risk factors, quality of
life, and health-related behaviors.
Methods
Study design and participants
The framework for the Grenada Heart Project has been
based on the peer group-based lifestyle intervention in
Spain, as reported previously.8 Eligible participants were
18 to 85 years of age with at least two CV risk factors,
which included: elevated blood pressure (systolic ≥120
mm Hg and/or diastolic ≥80 mm Hg), overweight or
obese (BMI ≥25 kg/m2; waist circumference N40 inches
for men, N35 inches for women), elevated blood glucose
level (random glucose≥140 mg/dL), low level of physical
activity (b150 minutes of at least moderate physical
activity/week), low fruit and vegetable intake (b2
servings/day), hyperglycemia (generously defined as
fasting glucose N100 mg/dL), dyslipidemia (total choles-
terol ≥250 mg/dL or LDL-C ≥130 mg/dL), or current
smoking. The participants with ≥2 CV risk factors were
contacted from the original GHP cross-sectional study,5from five parishes around the island: the parishes of St
David's, St Andrew's, St George's, St John's, and St Mark's.
All eligible participants were invited to attend an intense
educational lecture series. They were required to
participate in at least three workshops in order to enroll
in the study. The workshop themes included motivation
to change, physical activity, healthy diet, smoking
cessation, blood pressure, and stress management. The
research team, local experts, and respected community
members presented a general overview of the lifestyle
intervention and participants had an opportunity to ask
questions. Interested participants completed the written
consent after the educational lectures. Upon consenting,
participants received a blank notebook and health
literacy materials/brochures provided by the American
Heart Association such Easy Food Tips for Heart-Healthy
Eating (adapted for Grenadian diet), Just Move, Con-
trolling Your Risk Factors, and Understanding and
Controlling High Blood Pressure. These materials can be
accessed online at the American Heart Association
Website (https://www.heart.org/en/health-topics/
consumer-healthcare/order-american-heart-association-
educational-brochures). The educational materials aimed
to promote management of risk factors and the notebook
provides a means of recording lifestyle behaviors, such as
health goals, blood pressure values, and eating habits.
Individuals were then randomized in a 1:1 allocation to
the peer group intervention or the self-management
control group stratified by parish; the stratification
preventing imbalance between the treatment groups in
each parish.9Study intervention
We followed the Template for Intervention Descrip-
tion and Replication (TIDieR) guide10 to describe the
intervention (refer to supplemental TIDieR Checklist).
The control group received the series of educational
lectures at the time of enrollment, followed by self-
management for 1 year. At enrollment, participants
were instructed how to measure their weight and
blood pressure accurately, and scales as well as blood
pressure machines were distributed at community
health centers in each parish for self-monitoring. The
intervention group was organized into groups of 8–12
individuals in their local parish. A “peer leader” was a
community lay-person selected from motivated individ-
uals willing to undergo additional training from the
research staff to moderate the peer groups and take
attendance at group meetings. The leaders underwent
an additional three-hour training session on leadership
and communication skills in addition to the relevant
healthy behavior promotion.8
The peer group meetings were planned to meet monthly
for 1 year. The peer group leaders were educated using
evidence-based guidelines, and encouraged to promote 150
Figure 1
Educational lecture topics.
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five fruits and vegetables daily, smoking cessation, and blood
pressure management (Figure 1).11-15 Peer leaders were
provided topics to discuss at the monthly meetings, such as
low salt diet and hypertension, diabetes prevention, coping
strategies for stress, and smoking cessation (Supplemental
Table I); along a blood pressure machine with two different
cuff sizes. Leaders were able to adapt themes for each
meeting to their particular interest. For example if they did
not have any smokers in their group, they could skip the
‘smoking cessation’ group meeting. The Project administra-
tor in Grenada made routine visits to each group to
encourage and monitor the attendance, and to receive
feedback from the group leader. Although group leaders
were provided attendance sheets, this information was not
systematically collected because of different issues.
Data collection
The study team in Grenada called individuals by
telephone to invite them to participate. All assessments
were conducted at the local community health clinics
with the cooperation of local nurses. Data were collected
at baseline and at 12 months after completion of the
intervention, with an interim assessment at 6 months.
Blood pressure, anthropometric measures, and a detailed
questionnaire were measured at each visit. A lipid panel
was assessed at the final visit using a point of care
machine (LDX, Abbott). Blood pressure was obtained
thrice using an OMRON automatic blood pressure device
(OMRON Healthcare Inc) with an appropriate cuff size.
Height and weight were measured using a stadiometerand calibrated scale. The survey was administered in the
local language by Grenadian personnel and data was
recorded on a Samsung Galaxy tablet (2014). This
interviewer-administered questionnaire required approx-
imately 20 minutes to complete, and included socio-
demographic data, blood pressure, anthropometric
measures, a modified World Health Organization Step-
wise questionnaire,16 the International Physical Activity
Questionnaire (IPAQ),17 a lifestyle assessment, and the
SF-36 quality of life questionnaire.18,19 Coronary disease
was defined as being told by a healthcare provider of
having a heart attack, angina, or chest pain. Elevated
blood pressure was defined as systolic blood pressure
≥120 mm Hg or diastolic blood pressure ≥80 mm Hg.
BMI was defined as overweight if BMI was ≥25 kg/m2
and b30 kg/m2 and obese if BMI was ≥30 kg/m2. Low
physical activity was defined as less than 150 minutes of
moderate activity per week or less than 75 minutes of
vigorous activity. Poor nutritional intake was defined as
less than three servings of fruit and/or vegetables daily.
Smoking was defined through self-report as smoking any
type of tobacco daily.
Outcomes
The primary outcome was the difference between
groups in the change from baseline of the Fuster-BEWAT
score (FBS) at the completion of the 12-month interven-
tion. FBS is a composite, non-laboratory based score,
designed to provide a reliable low cost indicator of CV
health.8,20,21 The overall score ranges from 0 (poor
health) to 15 (ideal cardiovascular health), comprising a
Figure 2
CONSORT-style study flow diagram.
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consumption (range, 0-3), body-mass index (range, BMI)
(0-3), smoking habits (range, 0-3), and blood pressure
(range, 0-3). The details for the calculation of the FBS at
baseline and follow-up assessments, alongside the inverse
association of the FBS with the presence and extent of
subclinical atherosclerosis, have been previously pub-
lished.8,20 As a secondary outcome, a quality of life score
was also calculated, based on the SF-36 survey score (SF-
36 ranges from 0 to 100 and converted to a score category
0-3). The physician investigators counseled participants
regarding their results at the completion of the survey.
Statistical analysis
The sample size calculation was based on data available
to us from the Fifty-fifty study.8 Assuming a similar and
common standard deviation (SD) for the FBS of 2.3, to
detect a 10% difference in the change in FBS from
baseline to 1 year of follow up between the control and
intervention groups, with 80% power and type I errorrate of 0.05, a sample size of 342 was determined to be
adequate. Accounting for a 10% drop out rate, and
allowing for additional loss to follow up, we aimed to
randomize approximately 400 participants.
Continuous variables are reported as mean and SD while
discrete variables are reported as frequencies and percent-
ages, unless otherwise specified. The Student t test was
applied to assess the mean score differences at baseline and
follow-up between groups. Linear mixed-effects models
were used to assess the adjusted change in the composite
FBS from baseline to 1 year of follow-up. Fixed effects were
the corresponding baseline score (as a continuous variable),
and treatment group. The same approach was used for the
analysis of the change in the individual components of the
FBS and the SF-36 score. Every attempt was made to follow
all enrolled participants irrespective of allocation or
treatment withdrawal. All participants were included in
the analysis in the groups towhich theywere randomized. A
complete-case intention-to-treat analysis was performed as
main analysis. Statistical significancewas defined as a 2-sided
Table I. Baseline characteristics of the participants enrolled in the
GHP-CHANGE trial
Characteristic Overall Control Intervention
No. of participants, n 402 196 206
Age, mean (SD) 51.4 (14.5) 51.8 (14.9) 51.1 (14.2)
Sex, n female (%) 265 (65.9) 131 (66.8) 134 (65.1)
Overweight or obese, n (%) 261 (64.9) 134 (68.4) 127 (61.7)
Diabetes, n (%) 77 (19.5) 45 (23.2) 32 (15.9)
Known hypertension, n (%) 138 (34.4) 68 (34.9) 70 (34.0)
Current smoking, n (%) 18 (4.5) 8 (4.1) 10 (4.9)
Low fruit intake*, n (%) 217 (54.0) 109 (55.6) 108 (52.4)
Low vegetable intake*, n (%) 240 (59.7) 121 (61.7) 119 (57.8)
Low physical activity†, n (%) 196 (50.9) 97 (52.4) 99 (49.5)
Fuster-BEWAT score, mean (SD) 8.7 (2.6) 8.5 (2.6) 8.9 (2.6)
Quality of life score, mean (SD) 2.1 (1.1) 2.1 (1.1) 2.2 (1.0)
*Two servings or less per day of fruits or vegetables. †Less than 150 minutes of
moderate or 75 minutes of vigorous exercise per week. Percentages based on total
non-missing data available for each variable. Fuster-BEWAT Score (FBS) range 0 to
15. Quality of life score range 0 to 3. SD: standard deviation.
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STATA version 15.0 (StataCorp, College Station, Texas).
Recruitment
Of the 2827 original GHP participants, there were 794
participants with 2 or more CV risk factors. Of those, 453
participants were successfully contacted. Of those willing to
participate, 402 attended the educational lectures, enrolled
in the study, and completed baseline data collection and the
survey questionnaire. Informed written consent was obtain-
ed from all participants. The Institutional Review Boards of
Mount Sinai Hospital and St. George's University in Grenada
both approved of the final protocol. The trial is registered at
clinicaltrials.gov under NCT02428920.
Results
The GHP-CHANGE study CONSORT flow diagram is
presented in Figure 2. The total study population
consisted of 402 individuals randomized within parish
blocks.
Baseline characteristics of the participants enrolled in
the study are described in Table I. Two-thirds of the
participants were female, with a mean age of 51.4 years
(SD 14.5). A review of the CV risk factors reveals that we
recruited a relatively high-risk cohort. Two thirds of the
participants qualified as overweight or obese, approxi-
mately 50% were physically inactive, 20% reported
diabetes, and 35% were hypertensive. Nearly two thirds
(62%) of the participants aged 60 and above had three or
more risk factors.
Complete follow up data was available for 368
participants (n = 34, 8.5% drop out), who were included
in the analysis. Baseline characteristics of the participants
included and excluded in the complete-case intention-to-
treat analysis are described in Supplemental Table II.Number of participants who attended each group session
was recorded, but individual participant level data was
not available for analysis.
Overall Fuster-BEWAT and components' mean values
and mean differences at baseline and follow-up of
participants included in the analysis are described in
Supplemental Table III. Baseline mean FBS was 8.9 (SD
2.5) and 8.5 (SD 2.7) in the intervention and control
group, respectively (P = .077). At one-year of follow-up,
the overall FBS was significantly different between the
peer group intervention and control groups [9.1 (SD 2.7)
vs 8.5 (SD 2.6), P = .028, Figure 3 and Supplemental
Table III.
As primary outcome, the difference between groups in
the change of FBS from baseline to 1 year was 0.31 points
(95% confidence interval −0.12 to 0.75 points; P = .154;
Figure 3 and Table II). As secondary analyses, the
components of the score were examined individually;
there were no significant differences in the change of
components between the control and intervention group
(Table II). There was also no significant difference in the
quality of life between the control and intervention
groups.
Discussion
The goal of this randomized trial was to assess the
effectiveness of a one-year peer group intervention using a
composite score to measure cardiovascular health without
expensive laboratory or imaging tools. This trial evaluates a
novel approach to cardiovascular health in a LMIC. Our
results did not demonstrate a significant improvement of the
Fuster-BEWAT Score after the peer-group intervention for 1
year. Control individuals maintained their scores throughout
the study, suggesting that the education and counseling
provided to all participants during the initial enrollment and
assessments helped individualsmaintain their level of health,
but did not significantly change their CV risk factors at the
end of the trial.
The Fifty-fifty study in Spain demonstrated a significant
improvement in cardiovascular health as assessed by the
same composite score. We calculated our sample size and
anticipated effect size based on the available data. Notably,
the mean baseline FBS was higher in the Grenadian
population (higher score indicating better health), making
itmore challenging to demonstrate a significant 10% change.
Therefore, our study could be underpowered to see a
difference in FBS. The fact that each cardiovascular health
metric has equal weight in calculating the FBS might have
limited the ability to find significant differences. However,
this approach makes the score easy to understand and use,
both for clinicians and for patients to monitor the progress
toward health. Comparing these results to the successful
peer-group therapy in the Fifty-Fifty trial, we noted that
the primary driver of improvement in the FBS in Spain












Baseline One year follow-up
Control Intervention
p = 0.03p = 0.08
p = 0.15*
Change in Fuster BEWAT Scores at baseline and 1 year.*Comparing change in Fuster-BEWAT Score from baseline to 1 year of the control versus
the intervention group.
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common (only 5% prevalence in this study), leaving little
room for improvement. This rate was lower than
anticipated given recent data from the WHO indicates
that around 11% of the adult population of Grenada
smokes cigarettes daily,22 though it should be noted that
two thirds of the study participants were female, and
previous studies suggest that less than 5% of females
smoke in Grenada.5,6,22
These results suggest that there is a high-risk population
who participated in peer groups aimed toward lifestyle
changes. Nevertheless, these individuals do not have a
diagnosis of atherosclerotic heart disease, potentially a
critical difference compared to studies on peer group or
peer-led interventions for individuals with chronic diseases.
Individuals with chronic disease may be more motivated in
order to reduce symptoms or complications, whereas the
individuals in our study have not necessarily experienced
any sequelae of disease.
Peer group interventions have demonstrated varying
results.8,23-25 Best et al. systematically reviewed the effec-
tiveness of peer-led programs to increase physical activity,
and found that there were modest improvements in the
physical activity of the participants,23 yet they were short
interventions, and more research is needed regarding
retention and sustainability. Peer support groups have also
been attempted for cardiac disease, with some positive
results, though it remains difficult tomake conclusions based
on the heterogeneity of studies.26-28 Another critical
difference between our study and others is that we focused
on comprehensive lifestyle changes rather than just smokingcessation or physical activity alone. Typically, poor health
habits tend to cluster together, but it remains unclear
whether targeting multiple health behaviors is superior to
targeting a single habit.29-32
As with other lifestyle interventions, participation in this
trial was voluntary, which may lead to selection bias.
Participants willing to enroll in the study may be more likely
to change their habits, regardless of their group assignment.
A participant's readiness to change in the “stages of change”
model prior to the studymight play a prominent role in their
success.33 Thebloodpressure and anthropometricmeasures
were recorded by research staff, but the survey data are self-
reported, which may underestimate the true incidence of
vascular risk factors due to a lack of health literacy or access
to primary/preventive care. Additionally, in a close-knit
community like that ofGrenada, there is a possibility of cross-
over in the study, biasing the results toward the null. The
peer-led group intervention took place on amonthly basis, at
the convenience of the participants. Anecdotal feedback
from participants suggested more frequent meetings could
reinforce their positive lifestyle changes. Nevertheless, we
were not able to quantitatively assess the adherence or
fidelity to the intervention, which may be important factors
influencing the intervention effects.8 The ideal duration for a
lifestyle intervention remains unclear. To derive the
maximum benefit, behavior changes made during any
lifestyle intervention should ideally continue throughout
life.34-36 Peer-support strategies have been shown to be cost-
effective in specific situations, such as the control of type 2
diabetes37-39; however, additional studies are needed to
determine their cost-effectiveness in other settings.
Table II. Change from baseline to 1 year in the overall Fuster-BEWAT score, and its components
Within-group differences Between-group difference
Scale range Control (95% CI) Intervention (95% CI) Difference (95% CI) P
Fuster-BEWAT overall⁎ 0–15 0.05 (−0.31 to 0.41) 0.19 (−0.12 to 0.49) 0.31 (−0.12 to 0.75) .154
B-Blood pressure 0–3 0.07 (−0.08 to 0.22) −0.02 (−0.17 to 0.13) −0.03 (−0.23 to 0.16) .735
E-Exercise 0–3 −0.10 (−0.32 to 0.13) 0.05 (−0.15 to 0.25) 0.19 (−0.07 to 0.45) .157
W-Weight 0–3 −0.07 (−0.20 to 0.07) −0.06 (−0.18 to 0.06) 0.09 (−0.07 to 0.25) .283
A-Alimentation 0–3 0.09 (−0.05 to 0.24) 0.20 (0.07 to 0.32) 0.08 (−0.07 to 0.23) .289
T-Tobacco 0–3 0.04 (0.00 to 0.08) 0.02 (−0.02 to 0.06) −0.02 (−0.06 to 0.02) .393
Quality of life† 0–3 0.31 (0.17 to 0.45) 0.18 (0.04 to 0.32) −0.03 (−0.18 to 0.11) .649
Data are presented as mean differences and 95% confidence intervals (CI) as derived from linear mixed-effects models. Fixed effects were the corresponding baseline score and
treatment group. Between-group differences calculated as intervention vs. control.
⁎Overall Fuster-BEWAT Score (FBS) is a composite score ranging from 0 to 15. It consists of Blood pressure (0–3), Exercise (0–3), Weight (0–3), Alimentation (0–3), and Tobacco
(0–3). A higher score implies better health.
†Quality of life is based on the SF-36 question score. An SF 36 score of N80 translated to a QOL score of 3, 71–80 translated to a score of 2, 51–70 translated to a score of 1, and
b=50 translated to a score of 0.
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preventative efforts in LMICs may be particularly challeng-
ing. Themain cost of a peer group intervention such as GHP-
CHANGE is the human capital required to organized and
execute the intervention. Healthcare providers are required
to conduct periodic assessments, interpret results and
counsel participants on their progress and goals. Specialized
multidisciplinary teams (eg, physicians, nurses, community
health workers, etc) may be required to oversee and deliver
the intervention successfully.40 Particularly relevant is how
peer leaders can be supported outside research studies;
although they are generally volunteers, peer leaders need
training and some level of supervision.41 Therefore, for a
successful peer group intervention, there needs to be a
structural framework for oversight. As with all lifestyle
interventions, individuals might prioritize other issues
limiting the participation in peer-group sessions such as
work commitments, lack of time, health issues, location and
timing issues, and family issues or commitments.42 Finally,
peer-support programs require consideration of organiza-
tional issues, local needs and resources, as well as
community engagement and the involvement of
stakeholders.43
This intervention demonstrated that a low-cost, peer-
group-based intervention to promote heart healthy behav-
iors is feasible in a LMIC. The baseline prevalence of obesity,
physical inactivity, and poor nutritional habits, particularly in
middle-aged women, suggest that this is a critical target
population. Given the prevalence of obesity, hypertension,
diabetes, and physical inactivity, this data suggests that in the
future there could be a sharp rise in the incidence of
cardiovascular disease.44 For a small middle-income country
such as Grenada, battling chronic cardiovascular disease
could be devastating for their resource-poor healthcare
system.
Previous data fromour grouphas demonstrated that group
dynamics seem to maintain the initial increase in score
whereas the effect of education alone fades over time.8 Weare currently conducting a trial called FAMILIA (Family-based
Approach in a Minority Community Integrating Systems-
Biology for Promotion of Health) in Harlem, New York,
which also utilizes the peer-group model for health
promotion (NCT02481401).45,46 We believe that a holistic
approach to heart health and peer support are critical to
successful behavior change.Conclusions
In the GHP-CHANGE community-based trial, a monthly
peer group-based cardiovascular health promotion inter-
vention did not demonstrate a significant improvement in
the Fuster-BEWAT Score of participants at 1 year as
compared to the control group. Further studies should
assess the effects of low-cost lifestyle interventions in
LMICs.Acknowledgments
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